Sequential immune-related nephritis and pneumonitis during immune checkpoint inhibitor therapy: a case report - Top-Institutions - MDSpire

Sequential immune-related nephritis and pneumonitis during immune checkpoint inhibitor therapy: a case report

  • By

  • Haocheng Zhao

  • Shanshan Lin

  • Lingzhi Wu

  • Wenqiu Wu

  • May 13, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Mass General Brigham
    Mass General Brigham

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Stephenson Cancer Center, University of Oklahoma
    Stephenson Cancer Center, University of Oklahoma

    Oklahoma City, OK

    Key Differentiators

    • Oncology

  • #4

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #5

    Taipei Medical University Hospital
    Taipei Medical University Hospital

    Taipei, Taiwan

    Key Differentiators

    • Oncology

Original Source(s)

Sequential immune-related nephritis and pneumonitis during immune checkpoint inhibitor therapy: a case report

  • by Haocheng Zhao, Shanshan Lin, Lingzhi Wu, Wenqiu Wu

  • May 13, 2026

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant